Macdonald Henderson Solicitors

You are in: HomeNews › Macdonald Henderson Advises Emblation on Eight Figure Investment by Apposite – 25th May 2021

Macdonald Henderson Advises Emblation on Eight Figure Investment by Apposite – 25th May 2021 - Click for larger version Macdonald Henderson Advises Emblation on Eight Figure Investment by Apposite – 25th May 2021

Macdonald Henderson has advised fast growing medical device company Emblation, on an eight figure investment by healthcare investor Apposite Capital to support its international growth and broaden its go-to market offering.

Created in 2007 by joint co-founders Gary Beale and Eamon McErlean, (the inventors of the technology) Emblation designs, manufactures and commercialises next generation microwave-based solutions for a range of skin conditions.

The award-winning and clinically proven technology, SWIFT, offers a non-ablative treatment for common and plantar warts.

Emblation’s products are also used in the treatment of certain cancers.

Emblation’s systems are currently sold in the UK, North America and Australia, and have been used in over 130,000 treatments to date.

Emblation’s medical devices can be found in thousands of clinics and hospitals across the UK, North America, and Australia, and the company is headquartered in Alloa, central Scotland, UK.

Gary Beale, CEO, commented: “We are pleased to have secured an investment from Apposite Capital which will allow us to accelerate our international expansion into new and existing markets as well as continue to build on our technology platform and deliver ground-breaking clinical results.

Apposite immediately recognised the growth potential of our technology, and I am particularly excited to be working with the firm given their understanding of the sector and their expertise in scaling-up businesses like ours.”

About Macdonald Henderson, Mr Beale commented:

“Macdonald Henderson played an integral role throughout this transaction, and we benefited greatly from the experience and guidance of David Beveridge, Laura McKnight and their team.”

We are pleased to have advised Emblation from its inception through to the completion of this transaction, and wish the parties and stakeholders every success for the future in developing its life enhancing and life-saving technologies.

Advisers to Emblation: William Blair (corporate finance), Macdonald Henderson (legal), Mazars (accounting and tax); Advisers to Apposite Capital: Stephenson Harwood (legal), KPMG (accounting and tax)

Last updated: 2.07pm, Wednesday 9th June 2021

Latest News and Events

We are delighted to share an article by our colleague Laura McKnight (director) who has taken some time out from her busy corporate transactional role, to consider the post Covid M&A/investment deal market and highlight some key features to look out for.
Macdonald Henderson has advised fast growing medical device company Emblation, on an eight figure investment by healthcare investor Apposite Capital to support its international growth and broaden its go-to market offering.

Meet the Team at Macdonald Henderson